This is a cell supplies order for experimental purposes for patients with covid-19 under the protocol studies at the clinical center.
Ended Purchase Order Awarded Last action
- Contract number
- 75N90020P00323
- Awardee
-
Qiagen, LLC UEI W2GLKC92ZH73 Part of Qiagen N.V.
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,987
Award facts
- Contract value 100% obligated
- $24,987.30 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Germantown, MD, USA
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
About this award
The National Institutes of Health Clinical Center awarded a purchase order to Qiagen, LLC valued at $24,987.30 on March 30, 2020, for cell supplies to support experimental protocol studies treating patients with COVID-19. Place of performance is Germantown, Maryland. The order carries firm fixed price terms and is designated under the Coronavirus COVID-19 National Interest Action Code. Ultimate completion date is March 30, 2020.
Quick answers
Who was awarded contract 75N90020P00323?
75N90020P00323 was awarded to Qiagen, LLC by NIH Clinical Center (National Institutes of Health) on March 30, 2020.
How much is contract 75N90020P00323 worth?
The government has obligated $24,987 on 75N90020P00323.
Was contract 75N90020P00323 competed?
The extent of competition for 75N90020P00323 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award